Avanzanite

Series-A
avanzanite.com Biotech & Healthcare Amsterdam, The Netherlands
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced Nov 18, 2025
Investors 1 Backer
Decision Makers Profile Active

About Avanzanite

Avanzanite Bioscience improves access to orphan medicines across Europe through innovative commercialization and distribution partnerships, positively impacting patient lives.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Amsterdam, The Netherlands
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website avanzanite.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

Investors & Backers

1
MVM Life Science Partners

Funding History

1 Round
Series-A equity · Nov 18, 2025

Founders & Leadership

3

Adam Plich

FOUNDER, CEO & EXECUTIVE BOARD MEMBER

Work email & phone locked Unlock →

Anant Murthy

FOUNDER & BOARD MEMBER

Work email & phone locked Unlock →

Mark Bechter

Senior Vice President of Medical Affairs

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts